Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.

Lang Kuhs KA, Gonzalez P, Rodriguez AC, van Doorn LJ, Schiffman M, Struijk L, Chen S, Quint W, Lowy DR, Porras C, DelVecchio C, Jimenez S, Safaeian M, Schiller JT, Wacholder S, Herrero R, Hildesheim A, Kreimer AR, Costa Rica Vaccine Trial Group
J Infect Dis. 2014 210 (12): 1890-9

PMID: 24958910 · PMCID: PMC4271025 · DOI:10.1093/infdis/jiu357

MeSH Terms (16)

Adolescent Adult Cervix Uteri Costa Rica DNA, Viral Female Human papillomavirus 16 Human papillomavirus 18 Humans Papillomavirus Infections Papillomavirus Vaccines Prevalence Risk Factors Vulva Vulvar Diseases Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: